OncoImmunology (Dec 2022)

Spermidine rejuvenates T lymphocytes and restores anticancer immunosurveillance in aged mice

  • Francesca Castoldi,
  • Guido Kroemer,
  • Federico Pietrocola

DOI
https://doi.org/10.1080/2162402X.2022.2146855
Journal volume & issue
Vol. 11, no. 1

Abstract

Read online

Writing in Science, Al Habsi et al. show that spermidine boosts the efficacy of monoclonal antibodies targeting PD-L1 in aged tumor-bearing mice by enhancing fatty acid oxidation in CD8 T cells. These results open new therapeutic avenues to improve the effectiveness of anticancer immunotherapies in aged patients.

Keywords